Adagio Medical appoints Todd Usen as CEO; founder Olav Bergheim departs as CEO and Chairman

Adagio Medical Holdings, Inc.

Olav Bergheim resigns as CEO and Chairman effective Dec 13, 2024; receives severance of $1.2M cash plus contingent $300K.
Bergheim will serve as advisor for 12 months and receives an option for 338,398 shares of common stock.
Todd Usen appointed CEO and Director effective Dec 13, 2024; base salary $500K/year, bonus up to 50%, and option for ~5% fully diluted shares.
Orly Mishan appointed Chairperson of the Board effective Dec 13, 2024.
Bergheim's departure not due to disagreement with financial reporting or operations.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.